Cargando…
Overexpression of Endoplasmic Reticulum Oxidoreductin 1-α (ERO1L) Is Associated with Poor Prognosis of Gastric Cancer
PURPOSE: Gastric cancer is the second leading cause of cancer-related death worldwide. Although surgery is the standard curative treatment for gastric cancer, relapse occurs in a large number of patients, except in the case of early diagnosed gastric cancer. Following previous studies that identifie...
Autores principales: | Seol, So-Young, Kim, Chul, Lim, Jae Yun, Yoon, Sun Och, Hong, Soon Won, Kim, Jong Won, Choi, Seung Ho, Cho, Jae Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080819/ https://www.ncbi.nlm.nih.gov/pubmed/26987398 http://dx.doi.org/10.4143/crt.2015.189 |
Ejemplares similares
-
Molecular Characterization of Endoplasmic Reticulum Oxidoreductin 1 from Bombyx mori
por: Seo, Minchul, et al.
Publicado: (2015) -
Combined expression of protein disulfide isomerase and endoplasmic reticulum oxidoreductin 1-α is a poor prognostic marker for non-small cell lung cancer
por: Kim, Kyoung Min, et al.
Publicado: (2018) -
Endoplasmic reticulum oxidoreductin 1‐alpha deficiency and activation of protein translation synergistically impair breast tumour resilience
por: Varone, Ersilia, et al.
Publicado: (2022) -
Targeting the functional interplay between endoplasmic reticulum oxidoreductin-1α and protein disulfide isomerase suppresses the progression of cervical cancer
por: Zhang, Yini, et al.
Publicado: (2019) -
Non-native proteins inhibit the ER oxidoreductin 1 (Ero1)–protein disulfide-isomerase relay when protein folding capacity is exceeded
por: Moilanen, Antti, et al.
Publicado: (2020)